{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:02:11Z","timestamp":1784383331702,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":1309,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1017\/s1041610220000940","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T09:36:56Z","timestamp":1592473016000},"page":"587-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-3736","authenticated-orcid":false,"given":"Daniel J.","family":"Hoyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan K.","family":"Bindoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Clinnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan D.","family":"Bindoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita L.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610220000940_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/pgmj.2003.017236","article-title":"An approach to drug induced delirium in the elderly","volume":"80","author":"Alagiakrishnan","year":"2004","journal-title":"Postgraduate Medical Journal"},{"key":"10.1017\/S1041610220000940_bb0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/13607863.2013.832732","article-title":"Barriers to antipsychotic discontinuation in nursing homes: an exploratory study","volume":"18","author":"Azermai","year":"2014","journal-title":"Aging & Mental Health"},{"key":"10.1017\/S1041610220000940_bb0020","first-page":"CD00476","article-title":"Atypical antipsychotics for aggression and psychosis in Alzheimer\u2019s disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610220000940_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"Journal of Statistical Software"},{"key":"10.1017\/S1041610220000940_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0898264310381277","article-title":"Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis","volume":"23","author":"Bloch","year":"2011","journal-title":"Journal of Aging and Health"},{"key":"10.1017\/S1041610220000940_bb0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eurger.2013.11.005","article-title":"Barriers to discontinuation of chronic benzodiazepine use in nursing home residents: perceptions of general practitioners and nurses","volume":"5","author":"Bourgeois","year":"2013","journal-title":"European Geriatric Medicine"},{"key":"10.1017\/S1041610220000940_bb0040","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00228-014-1725-7","article-title":"Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study","volume":"70","author":"Bourgeois","year":"2014","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1017\/S1041610220000940_bb0045","first-page":"592","author":"Brodaty","year":"2018"},{"key":"10.1017\/S1041610220000940_bb0050","author":"Cohen-Mansfield"},{"key":"10.1017\/S1041610220000940_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jamda.2016.07.004","article-title":"Psychotropic drug prescription and the risk of falls in nursing home residents","volume":"17","author":"Cox","year":"2016","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S1041610220000940_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv055","article-title":"Use of benzodiazepines in Alzheimer\u2019s disease: a systematic review of literature","volume":"18","author":"Defrancesco","year":"2015","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1017\/S1041610220000940_bb0065","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. (2013). Neurocognitive Disorders. American Psychiatric Association. Available at: http:\/\/dsm.psychiatryonline.org.ezproxy.utas.edu.au\/doi\/full\/10.1176\/appi.books.9780890425596.dsm17; last accessed 24 January 2017."},{"key":"10.1017\/S1041610220000940_bb0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ggi.12707","article-title":"Relationship between restraint use, engagement in social activity, and decline in cognitive status among residents newly admitted to long-term care facilities","volume":"17","author":"Freeman","year":"2017","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1017\/S1041610220000940_bb0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1445-5994.1993.tb01433.x","article-title":"Trial of an intervention to reduce chronic benzodiazepine use among residents of aged-care accommodation","volume":"23","author":"Gilbert","year":"1993","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1017\/S1041610220000940_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-7-71","article-title":"Health-related Quality of Life among hospitalized older people awaiting residential aged care","volume":"7","author":"Giles","year":"2009","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1017\/S1041610220000940_bb0085","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"10.1017\/S1041610220000940_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jama.2017.7032","article-title":"Reducing excessive use of antipsychotic agents in nursing homes","volume":"318","author":"Gurwitz","year":"2017","journal-title":"Journal of the American Medical Association"},{"key":"10.1017\/S1041610220000940_bb0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-842X.2005.tb00063.x","article-title":"Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure","volume":"29","author":"Hawthorne","year":"2005","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1017\/S1041610220000940_bb0100","author":"Hawthorne","year":"2009"},{"key":"10.1017\/S1041610220000940_bb0105","series-title":"Construction and Utility Scaling of the Assessment of Quality of Life (AQoL) Instrument","author":"Hawthorne","year":"2000"},{"key":"10.1017\/S1041610220000940_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/geronj\/42.4.395","article-title":"Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES)","volume":"42","author":"Helmes","year":"1987","journal-title":"Journal of Gerontology"},{"key":"10.1017\/S1041610220000940_bb0115","first-page":"52","article-title":"Persistent use of psychotropic drugs in nursing home residents in Norway","volume":"17","author":"Helvik","year":"2017","journal-title":"BioMed Central Geriatrics"},{"key":"10.1017\/S1041610220000940_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40266-018-0518-6","article-title":"Clinical and economic outcomes of interventions to reduce antipsychotic and benzodiazepine use within nursing homes: a systematic review","volume":"35","author":"Hoyle","year":"2018","journal-title":"Drugs and Aging"},{"key":"10.1017\/S1041610220000940_bb0125","series-title":"The IPA Complete Guides to Behavioural and Psychological Symptoms of Dementia (BPSD): Specialists Guide","author":"International Psychogeriatric Association.","year":"2015"},{"key":"10.1017\/S1041610220000940_bb0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1532-5415.2000.tb02624.x","article-title":"The protective effect of social engagement on mortality in long-term care","volume":"48","author":"Kiely","year":"2000","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610220000940_bb0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ageing\/afx057","article-title":"Evidence for strategies that improve recruitment and retention of adults aged 65 years and over in randomised trials and observational studies: a systematic review","volume":"46","author":"Lacey","year":"2017","journal-title":"Age and Ageing"},{"key":"10.1017\/S1041610220000940_bb0140","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/gps.1108","article-title":"Psychometric properties and factor structure of the Neuropsychiatric Inventory Nursing Home version in an elderly neuropsychiatric population","volume":"19","author":"Lange","year":"2004","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3928\/00989134-20090731-01","article-title":"Psychotropic medication use among older adults: what all nurses need to know","volume":"35","author":"Lindsey","year":"2009","journal-title":"Journal of Gerontological Nursing"},{"key":"10.1017\/S1041610220000940_bb0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjopharm.2010.05.004","article-title":"Interventions to improve suboptimal prescribing in nursing homes: a narrative review","volume":"8","author":"Marcum","year":"2010","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S1041610220000940_bb0155","first-page":"438","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"Journal of the American Medical Association Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1017\/S1041610217002447","article-title":"A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern","volume":"30","author":"McMaster","year":"2018","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610220000940_bb0165","doi-asserted-by":"crossref","first-page":"e007382","DOI":"10.1136\/bmjopen-2014-007382","article-title":"Monetary costs of agitation in older adults with Alzheimer\u2019s disease in the UK: prospective cohort study","volume":"5","author":"Morris","year":"2015","journal-title":"BMJ Open"},{"key":"10.1017\/S1041610220000940_bb0170","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1212\/01.WNL.0000036904.73393.E4","article-title":"The incremental direct costs associated with behavioral symptoms in AD","volume":"59","author":"Murman","year":"2002","journal-title":"Neurology"},{"key":"10.1017\/S1041610220000940_bb0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0895-4356(02)00601-7","article-title":"Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) Instrument and comparison with the SF-36","volume":"56","author":"Osborne","year":"2003","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1017\/S1041610220000940_bb0180","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly","volume":"75","author":"Picton","year":"2018","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1017\/S1041610220000940_bb0185","series-title":"R: A Language and Environment for Statistical Computing.","author":"R Core Team.","year":"2017"},{"key":"10.1017\/S1041610220000940_bb0190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0844562117726253","article-title":"Social engagement and antipsychotic use in addressing the behavioral and psychological symptoms of dementia in long-term care facilities","volume":"49","author":"Saleh","year":"2017","journal-title":"Canadian Journal of Nursing Research"},{"key":"10.1017\/S1041610220000940_bb0195","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ggi.13528","article-title":"Predicting falls from behavioral and psychological symptoms of dementia in older people residing in facilities","volume":"18","author":"Sato","year":"2018","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1017\/S1041610220000940_bb0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0205","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"Journal of the American Medical Association"},{"key":"10.1017\/S1041610220000940_bb0210","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/gps.1749","article-title":"The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes","volume":"22","author":"Selbaek","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03325253","article-title":"Do behavioral disturbances predict falls among nursing home residents?","volume":"24","author":"Sylliaas","year":"2012","journal-title":"Aging Clinical and Experimental Research"},{"key":"10.1017\/S1041610220000940_bb0220","unstructured":"The Royal Australian & New Zealand College of Psychiatrists. (2016). Professional Practice Guideline 10: antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia [Online]. Available at: https:\/\/www.ranzcp.org\/Files\/Resources\/College_Statements\/Practice:Guidelines\/pg10-pdf.aspx; last accessed 26 April 2018."},{"key":"10.1017\/S1041610220000940_bb0225","unstructured":"The Royal Australian College of General Practitioners. (2015). Prescribing drugs of dependence in general practice, Part B [Online]. Available at: https:\/\/www.racgp.org.au\/your-practice\/guidelines\/drugs-of-dependence-b; last accessed 31 July 2017."},{"key":"10.1017\/S1041610220000940_bb0230","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamda.2014.06.012","article-title":"Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review","volume":"15","author":"Thompson Coon","year":"2014","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S1041610220000940_bb0235","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/gps.3858","article-title":"The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes","volume":"28","author":"van de Ven-Vakhteeva","year":"2013","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0240","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1017\/S104161021600082X","article-title":"Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate: the PROPER I-study","volume":"28","author":"van der Spek","year":"2016","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610220000940_bb0245","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jamda.2017.10.004","article-title":"Nursing staff distress associated with neuropsychiatric symptoms in young-onset dementia and late-onset dementia","volume":"19","author":"van Duinen-van den IJssel","year":"2018","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S1041610220000940_bb0250","article-title":"Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia","author":"Van Leeuwen","year":"2018","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"10.1017\/S1041610220000940_bb0255","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1741-6612.2010.00409.x","article-title":"Review of psychotropic medication in Tasmanian residential aged care facilities","volume":"29","author":"Westbury","year":"2010","journal-title":"Australasian Journal on Ageing"},{"key":"10.1017\/S1041610220000940_bb0260","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0004867418758919","article-title":"More action needed: psychotropic prescribing in Australian residential aged care","volume":"53","author":"Westbury","year":"2019","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0265","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5694\/mja17.00857","article-title":"RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities","volume":"208","author":"Westbury","year":"2018","journal-title":"Medical Journal of Australia"},{"key":"10.1017\/S1041610220000940_bb0270","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/medethics-2011-100119","article-title":"Impact of the demand for \u2018proxy assent\u2019 on recruitment to a randomised controlled trial of vaccination testing in care homes","volume":"39","author":"Whelan","year":"2013","journal-title":"Journal of Medical Ethics"},{"key":"10.1017\/S1041610220000940_bb0275","unstructured":"WHO Collaboration Centre for Drug Statistics Methodology. (2013). Guidelines for ATC Classification and DDD Assignment 2014 (17th edn.), Oslo. Available at: http:\/\/sifac.it\/wp-content\/uploads\/2013\/12\/dice1838.pdf."},{"key":"10.1017\/S1041610220000940_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00019442-200002000-00010","article-title":"The use of the neuropsychiatric inventory in nursing home residents: characterization and measurement","volume":"8","author":"Wood","year":"2000","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0285","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/gps.2499","article-title":"Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory","volume":"26","author":"Zuidema","year":"2011","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000940_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000096681","article-title":"Agitation in Dutch institutionalized patients with dementia: factor analysis of the Dutch Version of the Cohen-Mansfield Agitation Inventory","volume":"23","author":"Zuidema","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610220000940_bb0300","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/gps.4014","article-title":"Nurses in distress? An explorative study into the relation between distress and individual neuropsychiatric symptoms of people with dementia in nursing homes","volume":"29","author":"Zwijsen","year":"2014","journal-title":"International Journal of Geriatric Psychiatry"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224035695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224035695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610220000940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:28:11Z","timestamp":1736411291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224035695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1041610224035695"],"URL":"https:\/\/doi.org\/10.1017\/s1041610220000940","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610220000940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Psychogeriatric Association 2020. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}